Although IBC do not exhibit a specific expression profile, they tend to aggregate poor prognosis breast cancer clusters, being commonly of basal-like subtype, showing Her-2 amplification, EGFR overexpression and lacking estrogen and progesterone receptors. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.